DIRECTOR DEALINGS: GW Pharmaceuticals Chairman Sells 300,000 Shares

Fri, 28th Oct 2016 16:24

LONDON (Alliance News) - GW Pharmaceuticals PLC Friday said Chairman Geoffrey Guy sold a total of 300,000 shares in a series of transactions.

Guy sold 31,682 shares at 790 pence each on Friday, 138,318 shares at 804p each on Thursday and a further 130,000 shares at 808p each on Wednesday.

Last week the biopharmaceuticals firm said it intends to cancel its listing on AIM in London and will instead trade exclusively on New York's NASDAQ market.

The stock closed down 0.7% at 793.00p Friday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Related Shares

More News

3 Feb 2021 12:49

Jazz Pharmaceuticals to buy GW Pharmaceuticals for $7.2bn

(Sharecast News) - Jazz Pharmaceuticals has agreed to buy GW Pharmaceuticals for $7.2bn.

26 Nov 2018 15:49

GW Pharmaceuticals stock flies 4.8% after reporting positive test trial

(Sharecast News) - GW Pharmaceuticals stock rose by 4.8% on Monday after it announced positive test results from new cannabis-based drug trials.

12 Feb 2017 15:06

Sunday newspaper round-up: Inflation, RBS, Brexit defeat, BAE Systems

(ShareCast News) - Higher food and fuel prices drove inflation to a three-year zenith of 2% in January, up from 1.6% in December, with more increases ...

19 Oct 2016 08:20

GW Pharmaceuticals to cancel London listing, keep Nasdaq

(ShareCast News) - GW Pharmaceuticals plans to cancel its shares from trading on AIM on 5 December, with the last day of trading on the 2nd, but will ...